The Impact of the New WHO Antiretroviral Treatment Guidelines on HIV Epidemic Dynamics and Cost in South Africa

• Jan A. C. Hontelez ,

  * E-mail: j.hontelez@erasmusmc.nl

  Affiliations Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa, Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Sake J. de Vlas,

  Affiliation Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands

  ⨯
• Frank Tanser,

  Affiliation Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa

  ⨯
• Roel Bakker,

  Affiliation Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands

  ⨯
• Till Bärnighausen,

  Affiliations Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa, Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Marie-Louise Newell,

  Affiliation Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa

  ⨯
• Rob Baltussen,

  Affiliation Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Mark N. Lurie

  Affiliation Department of Epidemiology and the International Health Institute, Warren Alpert Medical School, Brown University, Providence, Rhode Island, United States of America

  ⨯